Family-partnered Delirium Prevention, Detection, and Management in the ICU
Condition(s) studied
Investigational drug(s) / intervention(s)
Standard of Care: Patients and family caregivers will receive standard of care, which varies by study site, but includes guideline-recommended interventions by the clinical team to prevent and manage delirium.
Delirium Education, Prevention, and Management: Patients and family caregivers will be provided with a validated education module on the signs and risk factors of delirium, in addition to delirium detection, prevention, and management strategies. The material will be provided as a six-minute video or as a paper booklet. Families will practice identifying delirium with the Family ICU Delirium Detection Instrument (FIDDI), using previously validated case vignettes of hypothetical ICU patients. Family caregivers will also be provided with a daily checklist to complete, detailing non-pharmacological strategies to prevent and manage delirium (i.e., orientation, mobility, and environmental cues). Delirium detection by family caregivers will be assessed by the FIDDI and communicated to the bedside nurse.
Study summary
Almost half of critically ill patients experience delirium. Delirium is associated with impaired cognition, mortality, and increased healthcare costs. Family members of critically ill patients are also at risk for adverse consequences such as depression and anxiety.
One strategy that may help to improve outcomes is to engage family members in the prevention, detection, and management of delirium. This study will employ an educational module to educate families on delirium symptoms, how delirium can be identified, and how to prevent and manage delirium using non-pharmacological strategies.
Family member delirium detection may result in earlier and more accurate recognition of delirium as well as meaningful family involvement, and ultimately the potential for better patient and family outcomes. This study aims to determine the efficacy of employing family-administered delirium prevention, detection, and management in the critically ill, compared to standard of care. We hypothesize that family-administered delirium prevention, detection, and management in the critically ill will be superior to standard of care in:
1. Reducing psychological distress in family members,
2. Reducing the prevalence, duration, and severity of delirium in critically ill patients,
3. Increasing delirium identification in medical charts,
4. Increasing delirium knowledge in family members of critically ill patients, and
5. Reducing the burden of delirium experienced by family members and caregivers
Eligibility
Primary outcome measure(s)
- Family member symptoms of depression and anxiety — 3-months post-ICU discharge
Change in the proportion of major depressive disorder and generalized anxiety symptamology in family members of critical ill patients measured by the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) scores, compared between control and intervention
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Foothills Medical Centre | Calgary | Alberta |
More University of Calgary trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07896356 on ClinicalTrials.gov ↗ ← All trials in Canada